This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
SELECT Data: Enrollment Statistics
    Updated: 09/04/2003
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Quick Links

Funding Opportunities

NCI Publications

NCI Calendar

NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer

Temozolomide Plus Radiation Helps Brain Cancer

Confirmed: Raloxifene Drops Risk of Breast Cancer

Bortezomib Delays Progression of Multiple Myeloma

Annual Report to the Nation

Past Highlights
Need Help?
Related Pages
The SELECT Prostate Cancer Prevention Trial

SELECT, the largest-ever prostate cancer prevention trial, is testing selenium and vitamin E (alone or in combination) to see if these supplements may prevent prostate cancer. SELECT began enrolling patients on August 21, 2001, and hopes to enroll 32,400 men over a five-year period.

There are 435 SELECT sites throughout the United States, Puerto Rico, and Canada.

Recruitment snapshot

In the first two years of recruitment (August 21, 2001, to August 20, 2003):

  • 24,639 men have been enrolled, or 76 percent of the total enrollment goal.
  • Of these, 3,526 are African Americans, comprising 14 percent of the enrolled total

The median age of SELECT participants is 62. The oldest participant enrolled at the age of 93.

A diverse group of men have joined SELECT. As of August 20, 2003:

  • 79 percent are white.
  • 13 percent are African-American.
  • 5 percent are Hispanic (non-African-American).
  • 1 percent are Hispanic (African-American).
  • 1 percent are Asian/Pacific Islander.

Incidence of prostate cancer

  • In men, prostate cancer is the most common cancer after skin cancer.
  • Prostate cancer is the second highest cause of cancer death in men in the U.S.
  • African-American men in the U.S. have the highest prostate cancer rates in the world.

To get more information...

...or to locate a participating center, call 1-800-4-CANCER in the United States and Puerto Rico or 1-888-939-3333 in Canada. For a collection of material about SELECT, visit Digest Page: The SELECT Prostate Cancer Prevention Trial.

SELECT Enrollment by U.S. State & Puerto Rico as of Aug. 2003
U.S. State Number U.S. State Number
Alabama 124 Montana 31
Alaska 8 Nebraska 257
Arizona 475 Nevada 166
Arkansas 17 New Hampshire 6
California 2,259 New Jersey 235
Colorado 655 New Mexico 8
Connecticut 97 New York 868
Delaware 56 North Carolina 418
District of Columbia 516 North Dakota 256
Florida 625 Ohio 805
Georgia 258 Oklahoma 355
Hawaii 25 Oregon 278
Idaho 140 Pennsylvania 864
Illinois 1,493 Puerto Rico 948
Indiana 291 Rhode Island 25
Iowa 493 South Carolina 853
Kansas 333 South Dakota 59
Kentucky 328 Tennessee 357
Louisiana 247 Texas 1,364
Maine 6 Utah 250
Maryland 108 Vermont 43
Massachusetts 220 Virginia 234
Michigan 937 Washington 1,122
Minnesota 870 West Virginia 184
Mississippi 587 Wisconsin 425
Missouri 478    

SELECT Enrollment by Canadian Province as of Aug. 2003
Canadian Province Number Canadian Province Number
Alberta 57 Ontario 1,065
British Columbia 725 Québec 702
Nova Scotia 33    

Back to TopBack to Top

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health